Strong Procurement Orders
SIGA secured $122 million in procurement orders in Q3 2024, positioning the company for strong revenue performance.
Diverse Revenue Sources and International Expansion
Product sales include deliveries to the U.S. Strategic National Stockpile and new international markets, including Africa.
Outstanding Procurement Orders
At the end of Q3, SIGA had $146 million in outstanding procurement orders, indicating strong future revenue potential.
Strong Financial Performance
Product revenue for the nine months ended September 30, 2024, was $53 million, with a net income of $13 million.
Strategic In-Licensing
SIGA announced an exclusive license for a portfolio of preclinical monoclonal antibodies from Vanderbilt University, expanding its pipeline.
Strong Balance Sheet
The company maintained a cash balance of $99 million with no debt at the end of September 2024.